02/09/2013 (Agence Europe) - Price-fixing: Lundbeck to appeal. Danish pharmaceutical company Lundbeck announced on 2 September that it will be appealing against the €93.8 million fine imposed on it by the European Commission in June for price-fixing in 2002 with generic medicines manufacturers in order to delay the release of generic versions of its flagship anti-depression drug Citalopram. In a press release, Lundbeck says the Commission's decision contains a number of serious errors of...